Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country
Sunday Odunke Nduka, Chiamaka Omelebere Ibe, Mercy Adamma Nwaodu, Chana Chapchet Robert

TL;DR
The study explores why community pharmacists in Nigeria rarely report adverse drug reactions and suggests ways to improve reporting practices.
Contribution
The paper identifies barriers to ADR reporting and proposes targeted strategies like training and feedback to improve reporting among pharmacists in a developing country.
Findings
Low ADR reporting was observed, especially among pharmacists with less than five years of experience.
Barriers included lack of awareness, absence of motivation, and insufficient feedback from NAFDAC.
Training, awareness campaigns, and simplifying the reporting process were suggested to improve ADR reporting.
Abstract
Reporting adverse drug reactions (ADRs) is fundamental in improving medication safety. Community pharmacists (CPs) being the first point of contact for individuals seeking healthcare in a community, play a significant role in ADR reporting. However, this has been poorly implemented in many countries including Nigeria. This paper aims to explore stakeholders’ perspectives on current reporting practices and suggest ways to enhance ADR reporting among CPs in Nigeria. This qualitative study employed a purposive sampling approach to identify key informants. Key informant interviews (KIIs) were conducted with 25 carefully selected pharmacists, using a semi-structured interview guide between July 2023 and August 2023. The interview transcripts were analyzed using a thematic content approach. While a low ADR reporting trend was observed among all participating pharmacists, it was notably higher…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Pharmaceutical Practices and Patient Outcomes · Pharmaceutical studies and practices
